| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/05/2015 | WO2015031808A2 Diagnostic methods and compositions for treatment of glioblastoma |
| 03/05/2015 | WO2015031726A2 Engineered primate l-methioninase for therapeutic purposes |
| 03/05/2015 | WO2015031667A2 Gitr antigen binding proteins |
| 03/05/2015 | WO2015031666A1 Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases |
| 03/05/2015 | WO2015030711A1 New use |
| 03/05/2015 | WO2015030149A1 Biomolecular group related to cell anti-aging |
| 03/05/2015 | WO2015030078A1 Therapeutic agent for ectocornea injury |
| 03/05/2015 | WO2015029948A1 Prophylactic or therapeutic agent for retinal disease caused by retinal pigment epithelium disorder |
| 03/05/2015 | WO2015029923A1 Ophthalmological preparation |
| 03/05/2015 | WO2015028941A1 New use |
| 03/05/2015 | WO2015028919A1 Agent for the treatment and prevention of cancer |
| 03/05/2015 | WO2015028637A1 Novel drug formulation |
| 03/05/2015 | WO2015028104A1 Novel drug combination |
| 03/05/2015 | WO2015028027A1 Anti-ADAM12 antibodies for the treatment of cancer |
| 03/05/2015 | WO2015027915A1 In-vivo individualized system immunological therapeutic method and device |
| 03/05/2015 | WO2014210504A9 Tape having transdermal analgesic properties |
| 03/05/2015 | US20150065946 Therapeutic applications of calcium electroporation to effectively induce tumor necrosis |
| 03/05/2015 | US20150065584 Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis |
| 03/05/2015 | US20150065581 Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
| 03/05/2015 | US20150065578 Compositions and Methods for Treating Metabolic Disorders |
| 03/05/2015 | US20150065572 Methods of treating or preventing prostate cancer |
| 03/05/2015 | US20150065570 Agent for inducing the synthesis of heat-shock proteins in human and animal cells |
| 03/05/2015 | US20150065559 METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM |
| 03/05/2015 | US20150065538 Trpa1 antagonists |
| 03/05/2015 | US20150065535 Method of restoring the incretin effect |
| 03/05/2015 | US20150065533 Benzyl-substituted carbamates and use thereof |
| 03/05/2015 | US20150065528 Paralytic shellfish poison |
| 03/05/2015 | US20150065522 Therapeutic compounds and uses thereof |
| 03/05/2015 | US20150065518 Methods of treating cancer having an active wnt/beta-catenin pathway |
| 03/05/2015 | US20150065517 New compounds |
| 03/05/2015 | US20150065511 Compositions and Methods for the Treatment of Presbyopia |
| 03/05/2015 | US20150065504 Antiviral compounds |
| 03/05/2015 | US20150065502 Antibacterial quinoline derivatives |
| 03/05/2015 | US20150065500 Modulators of ATP-Binding Cassette Transporters |
| 03/05/2015 | US20150065497 Modulators of atp-binding cassette transporters |
| 03/05/2015 | US20150065490 Organic compounds |
| 03/05/2015 | US20150065486 Methods for treating polycystic kidney disease |
| 03/05/2015 | US20150065478 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase |
| 03/05/2015 | US20150065471 Salts of 5-[(1r)-2-(amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one |
| 03/05/2015 | US20150065468 Biaryl acetamide compounds and methods of use thereof |
| 03/05/2015 | US20150065466 Novel dxr inhibitors for antimicrobial therapy |
| 03/05/2015 | US20150065465 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 03/05/2015 | US20150065464 Amide compounds, compositions and applications thereof |
| 03/05/2015 | US20150065458 Composition for Inactivating an Enveloped Virus |
| 03/05/2015 | US20150065457 Method of using cyclodextrin |
| 03/05/2015 | US20150065456 Agent for treatment and prevention of cancer |
| 03/05/2015 | US20150065447 Survival benefit in patients with solid tumors with elevated c-reactive protein levels |
| 03/05/2015 | US20150065445 Viral Polymerase Inhibitors |
| 03/05/2015 | US20150065419 Methods for treating metabolic disorders using fgf |
| 03/05/2015 | US20150065418 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 03/05/2015 | US20150065415 Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
| 03/05/2015 | US20150065414 Modified toll-like receptor 2 (tlr2) ligands as inhibitors of neutrophil recruitment |
| 03/05/2015 | US20150064286 Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
| 03/05/2015 | US20150064282 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 03/05/2015 | US20150064244 Konjac formulation and method for preparing the same |
| 03/05/2015 | US20150064240 MUC1 Based Glycolipopeptide Vaccine with Adjuvant |
| 03/05/2015 | US20150064238 Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke |
| 03/05/2015 | US20150064223 Biguanide Compositions and Methods of Treating Metabolic Disorders |
| 03/05/2015 | US20150064204 Gitr antigen binding proteins |
| 03/05/2015 | US20150064200 Methods and compositions for 6-phosphogluconate dehydrogenase (6-pgd) as a target for lung cancer therapy |
| 03/05/2015 | US20150064196 Substituted Hetero-Bicyclic Compounds, Compositions and Medicinal Applications Thereof |
| 03/05/2015 | US20150064193 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non-response alleles |
| 03/05/2015 | US20150064178 Diagnostic methods and compositions for treatment of glioblastoma |
| 03/05/2015 | US20150064176 Methods for treating conditions associated with masp-2 dependent complement activation |
| 03/05/2015 | US20150064175 Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic |
| 03/05/2015 | US20150064168 Cadherin-11 Inhibitors and Methods of Use Thereof |
| 03/05/2015 | US20150064161 Pharmacological vitreolysis |
| 03/05/2015 | US20150064160 Engineered primate cystine/cysteine degrading enzymes as antineogenic agents |
| 03/05/2015 | US20150064159 Engineered primate l-methioninase for therapeutic purposes |
| 03/05/2015 | US20150064148 Method for treating or preventing a pancreatic dysfunction |
| 03/05/2015 | US20150064134 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| 03/05/2015 | US20150064126 Use of chitosans for the treatment of nail inflammatory diseases |
| 03/04/2015 | EP2843049A1 Neuronal differentiation promoter |
| 03/04/2015 | EP2843048A1 NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF |
| 03/04/2015 | EP2842551A1 Complementary personal lubricant compositions |
| 03/04/2015 | EP2841104A1 Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use |
| 03/04/2015 | EP2841053A1 Treatment method for steroid responsive dermatoses |
| 03/03/2015 | US8969576 Substituted N-aryl pyridinones |
| 03/03/2015 | US8969575 Substituted N-Aryl pyridinones |
| 03/03/2015 | US8969574 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/03/2015 | US8969570 Beta-lactamase inhibitors |
| 03/03/2015 | US8969544 Combined use of PRAME inhibitors and HDAC inhibitors |
| 03/03/2015 | US8969417 Pharmaceutical compositions for treatment of Parkinsons disease |
| 03/03/2015 | US8969411 Vitamin C composition for use in the prevention and treatment of stretch other skin conditions and methods of using the same |
| 03/03/2015 | US8969400 Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound |
| 03/03/2015 | US8969398 Methods of treating hepatic encephalopathy |
| 03/03/2015 | US8969388 Substituted pyrazolone compounds and methods of use |
| 03/03/2015 | US8969381 Chemokine CXCR4 receptor modulators and used related thereto |
| 03/03/2015 | US8969377 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 03/03/2015 | US8969370 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 03/03/2015 | US8969366 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors |
| 03/03/2015 | US8969365 Thiopyrimidinecarboxamides as CXCR1/2 modulators |
| 03/03/2015 | US8969364 Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
| 03/03/2015 | US8969357 Methods for treating HCV |
| 03/03/2015 | US8969350 Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient |
| 03/03/2015 | US8969335 Benzonitrile derivatives as kinase inhibitors |
| 03/03/2015 | US8969334 Nitrogen containing compounds and their use |
| 03/03/2015 | US8969333 Therapeutic compositions and methods |
| 03/03/2015 | US8969327 Substituted androst-4-ene diones |
| 03/03/2015 | US8969325 TRPV1 antagonists |